Clinical Trial Update: Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating how a dopamine agonist affects the pharmacodynamics of levodopa in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dopamine agonist
• levodopa (levodopa)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED